NIH U01 Grants — Research Project — Cooperative Agreement

Recent U01 awards from NIH RePORTER

Examples of funded U01 projects across the last two fiscal years. The matching-award count comes from the full result set; funding totals, averages, rankings, and examples use the first 500 records returned by NIH RePORTER. Figures reflect a snapshot last refreshed on September 5, 2026.

Example U01 projects from the sample

• mproving Access to Nephrology Treatment and Care among Patients at Greatest Risk for Kidney Failure

  5U01DK137269-04
  Kimberly Arriola · EMORY UNIVERSITY, GA · $762,917 · awarded Aug 28, 2026 · NIH

  Improving Access to Nephrology Treatment and Care among Patients at Greatest Risk for Kidney Failure Nearly 15% of U.S. adults have chronic kidney disease (CKD),1 yet because symptoms are often “silent,”2 only an estimated 12-19% are aware of their disease. A lack of a diagnosis results in substantial delays in accessing necessary care, such as referral to…

• NAVIGATE Kidney: A Multi-Level Intervention to Reduce Kidney Health Disparities

  5U01DK137272-04
  Lilia Cervantes · UNIVERSITY OF COLORADO DENVER, CO · $764,433 · awarded Aug 28, 2026 · NIH

  Individuals experiencing progression from chronic kidney disease (CKD) to kidney failure face social challenges that contribute to kidney health disparities. Reducing the number of individuals who start KRT with a central venous catheter is critical because it is associated with a higher risk of fatal infection, non-fatal infection, hospitalization, and…

• INSPIRE: INterventionS for Promoting kIdney tRansplant Empowerment

  5U01DK137259-04
  Lili Chan · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY · $836,530 · awarded Aug 28, 2026 · NIH

  (30 Lines) Modified Grant Title: INSPIRE: INterventionS for Promoting kIdney tRansplant Empowerment Kidney transplantation (KTx) is the preferred treatment for patients with end-stage kidney disease. Despite recent changes to the kidney allocation system some individuals are less likely to receive a KTx evaluation, a multi-step process requiring patient…

• Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage

  3U01AI184132-03S1
  JEFFERY AULETTA · NATIONAL MARROW DONOR PROGRAM, MN · $111,904 · awarded Aug 27, 2026 · NIH

  Project Summary Severe combined immunodeficiency (SCID) is a group of genetic disorders that abrogate T cell development and function. Allogeneic hematopoietic cell transplantation (HCT) is the standard treatment for the disease and can be performed successfully in SCID patients without the high dose pre-HCT busulfan conditioning due to the unique capacity…

• Leveraging Prospective Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk Scores

  3U01CA261339-05S1
  Fei Chen · UNIVERSITY OF SOUTHERN CALIFORNIA, CA · $300,000 · awarded Aug 27, 2026 · NIH

  Abstract There are stark differences in the burden of certain cancers across populations. For example, in comparison to individuals of European ancestry, African American men have a ~67% higher incidence rate of prostate cancer and Asian/Pacific Islander men and women have a 70% and 95% higher incidence rate of liver cancer, respectively. These differences…

• Discovery Science Collaborative for CKDu

  5U01DK130060-06
  VIVEK BHALLA · STANFORD UNIVERSITY, CA · $1,839,499 · awarded Aug 26, 2026 · NIH

  PROJECT SUMMARY / ABSTRACT The overall goal of the Discovery Science Collaborative for CKDu Renal Science Core is to bring the best investigative methods and scientific technology to the problem of CKDu. We will work closely with Field Epidemiology Sites, the Scientific Data Coordinating Center, NIDDK Leadership, the External Oversight Committee, and HHEAR…

• Development of the anti-fentanyl monoclonal antibody, CSX-1004, for prophylaxis against fentanyl and fentanyl analog overdose

  5U01DA063352-02
  Andrew Barrett · CESSATION THERAPEUTICS, LLC, CA · $2,089,891 · awarded Aug 25, 2026 · NIH

  The opioid crisis in the United States has been dominated by illicitly manufactured fentanyl for a majority of the last decade, during which time over 400,000 Americans have died from unintentional overdose due to fentanyl or fentanyl analogs. The overdose reversal agent, naloxone, has been the cornerstone of opioid overdose management since 1971; however,…

• Mechanistic clinical trial of blocking the IL-4/13 axis in asthmatics precision phenotyped in an aeroallergen challenge chamber before, during and after receipt of dupilumab

  3U01AI158460-05S1
  Sunil Ahuja · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX · $490,019 · awarded Aug 19, 2026 · NIH

  7. Project Summary/Abstract We propose a high-impact, randomized, double-blind, placebo-controlled, mechanistic clinical trial aimed at elucidating the basis for the wide heterogeneity in severity of and treatment responses in persons with allergic rhinoconjunctivitis (ARC) and allergic asthma (AA). AA and ARC are highly prevalent, environmentally triggered…

• Mapping Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors

  5U01DK140764-03
  Aysenil Belger · UNIV OF NORTH CAROLINA CHAPEL HILL, NC · $559,495 · awarded Aug 19, 2026 · NIH

  Modified Project Summary/Abstract Section Type 1 diabetes (T1D) is associated with neurocognitive complications that may emerge early after diagnosis and worsen over time. Risk may be pronounced in children diagnosed prepubertally, as the developing brain is likely particularly vulnerable to dysglycemia, diabetic ketoacidosis (DKA), and other metabolic…

• Development of a Novel Therapeutic for Mitigating Radiation-Induced Microbiome Dysbiosis and Acute Gastrointestinal Syndrome

  3U01AI172853-04S2
  Constantinos Broustas · COLUMBIA UNIVERSITY HEALTH SCIENCES, NY · $48,754 · awarded Aug 19, 2026 · NIH

  SUMMARY A mass casualty radiation event, such as the detonation of an improvised nuclear device or radiological dispersal device, could lead to severe hemorrhage, multi-organ failure, and infection, potentially leading to sepsis and/or death. The hematopoietic system and the gastrointestinal (GI) tract are among the most vulnerable tissues to radiation…

• Bridging Function, Connectivity, and Transcriptomics of Mouse Cortical Neurons

  5U01MH130907-05
  ANTON ARKHIPOV · ALLEN INSTITUTE, WA · $2,201,458 · awarded Aug 18, 2026 · NIH

  Bridging Function, Connectivity, and Transcriptomics of Mouse Cortical Neurons The versatile and powerful functional properties of the brain are reflected in the neuronal activity patterns and computations, and their evolution over time due to learning, homeostatic plasticity, and other processes. The composition of brain circuits out of a large number of…

• Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage

  5U01AI184132-03
  JEFFERY AULETTA · NATIONAL MARROW DONOR PROGRAM, MN · $958,627 · awarded Aug 18, 2026 · NIH

  Project Summary Severe combined immunodeficiency (SCID) is a group of genetic disorders that abrogate T cell development and function. Allogeneic hematopoietic cell transplantation (HCT) is the standard treatment for the disease and can be performed successfully in SCID patients without the high dose pre-HCT busulfan conditioning due to the unique capacity…

Compare nearby NIH grant mechanisms

Searchers often land on U01 while deciding between adjacent NIH activity codes. Compare scope, NIH staff involvement, budget scale, and applicant stage before choosing a funding opportunity.